Suchergebnisse - "Gennari, Alessandra"

PubPharm (6)

1

International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer : European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations

enthalten in: The Lancet. Oncology | 2024

von Meattini, I. | Becherini, C. | Caini, S. | +39

2

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer : results from the OnCovid registry

enthalten in: The Lancet. Oncology | 2023

von Cortellini, A. | Tabernero, J. | Mukherjee, U. | +126

3

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe : results from the retrospective, multicentre, OnCovid registry study

enthalten in: The Lancet. Oncology | 2022

von Pinato, D. | Aguilar-Company, J. | Ferrante, D. | +147

4

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection : evidence from the OnCovid retrospective, multicentre registry study

enthalten in: The Lancet. Oncology | 2021

von Pinato, D. | Tabernero, J. | Bower, M. | +130

5

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE) : a multicentre, open-label, randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2018

von Colleoni, M. | Luo, W. | Karlsson, P. | +130

CommentIn: Lancet Oncol. 2018 Jan;19(1):13-15. - PMID 29158010

6

Anthracycline-free therapy for HER2-amplified breast cancer

enthalten in: The Lancet. Oncology | 2013

von Gennari, A. | Mastro, L.

CommentOn: Lancet Oncol. 2013 Oct;14(11):1121-8. - PMID 24007746

1
[1]